Clinical evaluation of daratumumab in combination with lenalidomide and bortezomib and with daratumumab， bortezomib， and dexamethasone for the treatment of relapsed and refractory multiple myeloma
The Journal of Practical Medicine
2025 Vol.41 (18): 2913-2919
[Abstract]
(22)
[PDF 542 KB]
(21)
Juan SHEN,Yong WANG,Qiuping WANG,Chen. LING
Relationship between the immune status of patients with multiple myeloma and the changes in the levels of detection of peripheral blood RDW-SD， sBCMA， sFLCR and prognosis
The Journal of Practical Medicine
2025 Vol.41 (8): 1161-1166
[Abstract]
(118)
[PDF 559 KB]
(174)
